Pregnancy and neonatal outcomes of artificial oocyte activation in patients undergoing frozen-thawed embryo transfer: a 6-year population-based retrospective study.

Bin LiYiwen ZhouZhiguang YanMenghui LiSongguo XueRenfei CaiYonglun FuQingqing HongHui LongMingru YinTong DuYun WangYanping KuangZheng YanQifeng Lyu

Published in: Archives of gynecology and obstetrics (2019)

Artificial oocyte activation with ionomycin does not adversely affect pregnancy and neonatal outcomes in patients undergoing frozen-thawed embryo transfer, which is beneficial to clinicians counseling patients on the risks of artificial oocyte activation.

Keyphrases

patients undergoing
pregnancy outcomes
end stage renal disease
preterm birth
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
palliative care
type diabetes
adipose tissue
hepatitis c virus
human health
climate change
skeletal muscle
weight loss